Long-term stability of quercetin nanocrystals prepared by different methods

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 10, 2012, Pages 1394-1402

  Kakran, Mitali ^a   Shegokar, Ranjita ^b   Sahoo, Nanda Gopal ^a   Gohla, Sven ^b,c   Li, Lin ^a   Müller, Rainer H ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c La Prairie Group   (Switzerland)

Author keywords

cavi precipitation; homogenization; milling; quercetin; stability

Indexed keywords

NANOCRYSTAL; QUERCETIN;

AGGLOMERATION; ARTICLE; BEAD MILLING; CAVI PRECIPITATION; CHEMICAL PHENOMENA; CONTROLLED STUDY; CRYSTALLIZATION; DISSOLUTION; DRUG DOSAGE FORM COMPARISON; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STABILITY; FREEZING; HIGH PRESSURE HOMOGENIZATION; INTERMETHOD COMPARISON; MOLECULAR STABILITY; PARTICLE SIZE; ROOM TEMPERATURE; STORAGE TEMPERATURE; X RAY DIFFRACTION; ZETA POTENTIAL;

ANTIOXIDANTS; CHEMICAL PRECIPITATION; CRYSTALLIZATION; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; NANOPARTICLES; PARTICLE SIZE; QUERCETIN; REFRIGERATION; SOLUBILITY; SOLVENTS; TEMPERATURE; TIME FACTORS; X-RAY DIFFRACTION;

EID: 84865862399     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01515.x     Document Type: Article

References (22)

1. Lipinski C,. Poor aqueous solubility-an industry wide problem in drug delivery. Am Pharm Rev 2002; 5: 82-85.
2. Lipinski CA, et al,. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46: 3-26. (Pubitemid 33653411)
3. Merisko-Liverside E, et al,. Nanosizing: a formulation approach for poorly-water soluble compounds. Eur J Pharm Sci 2003; 18: 113-120.
4. Gupta RB, Kompella UB, eds. Nanoparticle Technology for Drug Delivery. New York: Taylor & Francis, 2006.
5. Subramaniam B, et al,. Pharmaceutical processing with supercritical carbon dioxide. J Pharm Sci 1997; 86: 885-890. (Pubitemid 27344044)
6. Amidon GL, et al,. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12: 413-420.
7. Pattekari P, et al,. Top-down and bottom-up approaches in production of aqueous nanocolloids of low solubility drug paclitaxel. Phys Chem Chem Phys 2011; 13: 9014-9019.
8. Keck CM, Müller RH,. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur J Pharm Biopharm 2006; 62: 3-16. (Pubitemid 41736019)
9. Liversidge GG, et al,. Surface modified drug nanoparticles. US Patent 1992; 5: 145,684.
10. Kakran M, et al,. Production optimization of antioxidant quercetin nanocrystals. AAPS Annual Meeting and Exposition, Washington DC, USA 2011: Abstract 2265.
11. Müller RH, Moschwitzer J,. Method and device for producing very fine particles and coating such particles. Patent PCT/EP2006/009930, 2006.
12. Jagtap S, et al,. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem 2009; 16: 1451-1462.
13. Zhang JY, et al,. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. Int J Pharm 2006; 323: 153-160.
14. Kakran M, et al,. Quercetin nanocrystals: comparison of different production methods. Eur J Pharm Biopharm 2012; 80: 113-121.
15. Ader P, et al,. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 2000; 28: 1056-1067. (Pubitemid 30314704)
16. Müller RH, et al,. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001; 47: 3-19. (Pubitemid 32209229)
17. Teeranachaideekul V, et al,. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm 2008; 354: 227-234.
18. Mainardes RM, Evangelista RC,. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm 2005; 290: 137-144. (Pubitemid 40139053)
19. Kohane DS, et al,. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res A 2006; 77: 351-361. (Pubitemid 47233537)
20. Junghanns J-U, Müller RH,. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008; 3: 295-309.
21. Cussler EL,. Diffusion: Mass Transfer in Fluid Systems, 3rd edn. Cambridge: Cambridge University Press, 2009.
22. Jones DS,. Pharmaceutical Statistics. London: Pharmaceutical Press, 2002.